Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Nishimura

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 15, 2025
Boron neutron capture therapy with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP) for a head and neck squamous cell carcinoma (SAS) model miceKazuki Miura, Kai Nishimura, Minoru Suzuki, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 18, 2025
Comparative efficacy of reactor vs. accelerator-based boron neutron capture therapy in U87MG glioblastoma modelsKai Nishimura, Kazuki Miura, Hiroki Tanaka, et al.
ACS Omega|January 6, 2025
A Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture TherapyKai Nishimura, Shota Tanaka, Kazuki Miura, et al.
Molecular Pharmaceutics|August 27, 2020
Cyclic RGD-Functionalized <i>closo</i>-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture TherapyKazuki Kawai, Kai Nishimura, Satoshi Okada, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2022
Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumorKai Nishimura, Suzanna Harrison, Kazuki Kawai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2025
Alanine-serine-cysteine transporter-targeted small-molecule boron carriers for neutron capture therapy of L-4‑boronophenylalanine-refractory tumorsKazuki Miura, Tomoyuki Araki, Taiki Morita, et al.
Molecular Pharmaceutics|April 1, 2025
BODIPY-Based Photothermal Agent Incorporating Azulene for Enhanced NIR Absorption and Tumor AblationKai Nishimura, Mikiya Kato, Tomoya Fukui, et al.
Molecular Pharmaceutics|November 1, 2023
Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture TherapySatoshi Okada, Kai Nishimura, Qarri Ainaya, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2023
Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP)Kai Nishimura, Hideki Kashiwagi, Taiki Morita, et al.
EJNMMI Research|February 21, 2025
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]<sup>-</sup>) in breast cancer cellsAna Belchior, Bianca C Alves, Edgar Mendes, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 15, 2025
Boron neutron capture therapy with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP) for a head and neck squamous cell carcinoma (SAS) model miceKazuki Miura, Kai Nishimura, Minoru Suzuki, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 18, 2025
Comparative efficacy of reactor vs. accelerator-based boron neutron capture therapy in U87MG glioblastoma modelsKai Nishimura, Kazuki Miura, Hiroki Tanaka, et al.
ACS Omega|January 6, 2025
A Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture TherapyKai Nishimura, Shota Tanaka, Kazuki Miura, et al.
Molecular Pharmaceutics|August 27, 2020
Cyclic RGD-Functionalized <i>closo</i>-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture TherapyKazuki Kawai, Kai Nishimura, Satoshi Okada, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2022
Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumorKai Nishimura, Suzanna Harrison, Kazuki Kawai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2025
Alanine-serine-cysteine transporter-targeted small-molecule boron carriers for neutron capture therapy of L-4‑boronophenylalanine-refractory tumorsKazuki Miura, Tomoyuki Araki, Taiki Morita, et al.
Molecular Pharmaceutics|April 1, 2025
BODIPY-Based Photothermal Agent Incorporating Azulene for Enhanced NIR Absorption and Tumor AblationKai Nishimura, Mikiya Kato, Tomoya Fukui, et al.
Molecular Pharmaceutics|November 1, 2023
Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture TherapySatoshi Okada, Kai Nishimura, Qarri Ainaya, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2023
Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP)Kai Nishimura, Hideki Kashiwagi, Taiki Morita, et al.
EJNMMI Research|February 21, 2025
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]<sup>-</sup>) in breast cancer cellsAna Belchior, Bianca C Alves, Edgar Mendes, et al.
Pageof 2